This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Hill-Rom Holdings' CEO Presents At Morgan Stanley Global Healthcare Conference (Transcript)

Stocks in this article: HRC

Hill-Rom Holdings, Inc. (HRC)

Morgan Stanley Healthcare Conference Call

September 11, 2012 1:30 pm ET

Executives



John J. Greisch – President and Chief Executive Officer

Mark Guinan – Chief Financial Officer

Analysts

David R. Lewis – Morgan Stanley & Co. LLC

Presentation

David R. Lewis – Morgan Stanley & Co. LLC

My name is David Lewis, I’m the medical device analyst here at Morgan Stanley. It’s my pleasure to have all of us here, yet again for the second year. I’ll show two members of management, obviously John Greisch, as many of you know, as well as Mark Guinan, and Andy is in the audience as all of you know.

What I was going to have, may be do, I should have talked about this. But you want to give us a quick preamble of the business, and then we jump into Q&A?

John J. Greisch

Sure, thanks, David, great to be here. Just few quick highlights for those of you that aren’t familiar with the story. Hill-Rom market leading medical technology company global market leader in the hospital bed area, we’ve got about 70% installed base market share here in the United States. We’ve got a portfolio of products really focused on patient safety, enhancing patient outcomes, improving caregiver productivity, and caregiver safety in addition to beds, therapeutic surfaces, patient lifting, devices to help mobilized patients, get patients in and out of hospitals faster.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,805.73 -9.21 -0.05%
S&P 500 2,068.31 +1.28 0.06%
NASDAQ 4,768.4990 +10.2470 0.22%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs